Class information for:
Level 2: ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1619 6500 32.6 73%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
76 80406 HEMATOLOGY//LEUKEMIA & LYMPHOMA//HEMATOL

Classes in level below (level 1)


ID, lev. below Publications Label for level below
151 4065 ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS
13107 796 IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS//RADIATION THERAPY COMPLICATIONS//STANDARDIZED INCIDENCE RATE
15902 616 EXTRAMEDULLARY HEMATOPOIESIS//EXTRAMEDULLARY HAEMATOPOIESIS//EXTRAMEDULLARY HAEMOPOIESIS
16373 592 PARANEOPLASTIC VASCULITIS//PALMAR FASCIITIS//LEUKEMIC ARTHRITIS
21262 366 CHRONIC NEUTROPHILIC LEUKEMIA//CHRONIC NEUTROPHILIC LEUKAEMIA//COLONY STIMULATING FACTOR 3 RECEPTOR MUTATION
34680 65 AUTOIMMUNE MYELOFIBROSIS//DACRYOCYTES//ABNORMAL LOCALIZATION OF IMMATURE PRECURSORS ALIP

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ESSENTIAL THROMBOCYTHEMIA Author keyword 719 76% 8% 507
2 POLYCYTHEMIA VERA Author keyword 557 69% 7% 471
3 MYELOFIBROSIS Author keyword 516 66% 7% 483
4 MYELOPROLIFERATIVE NEOPLASMS Author keyword 260 75% 3% 186
5 PRIMARY MYELOFIBROSIS Author keyword 222 82% 2% 129
6 MYELOPROLIFERATIVE DISORDERS Author keyword 190 56% 4% 229
7 EXTRAMEDULLARY HEMATOPOIESIS Author keyword 169 65% 2% 160
8 JAK2V617F Author keyword 156 81% 1% 94
9 ESSENTIAL THROMBOCYTHAEMIA Author keyword 153 70% 2% 126
10 IDIOPATHIC MYELOFIBROSIS Author keyword 148 76% 2% 103

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ESSENTIAL THROMBOCYTHEMIA 719 76% 8% 507 Search ESSENTIAL+THROMBOCYTHEMIA Search ESSENTIAL+THROMBOCYTHEMIA
2 POLYCYTHEMIA VERA 557 69% 7% 471 Search POLYCYTHEMIA+VERA Search POLYCYTHEMIA+VERA
3 MYELOFIBROSIS 516 66% 7% 483 Search MYELOFIBROSIS Search MYELOFIBROSIS
4 MYELOPROLIFERATIVE NEOPLASMS 260 75% 3% 186 Search MYELOPROLIFERATIVE+NEOPLASMS Search MYELOPROLIFERATIVE+NEOPLASMS
5 PRIMARY MYELOFIBROSIS 222 82% 2% 129 Search PRIMARY+MYELOFIBROSIS Search PRIMARY+MYELOFIBROSIS
6 MYELOPROLIFERATIVE DISORDERS 190 56% 4% 229 Search MYELOPROLIFERATIVE+DISORDERS Search MYELOPROLIFERATIVE+DISORDERS
7 EXTRAMEDULLARY HEMATOPOIESIS 169 65% 2% 160 Search EXTRAMEDULLARY+HEMATOPOIESIS Search EXTRAMEDULLARY+HEMATOPOIESIS
8 JAK2V617F 156 81% 1% 94 Search JAK2V617F Search JAK2V617F
9 ESSENTIAL THROMBOCYTHAEMIA 153 70% 2% 126 Search ESSENTIAL+THROMBOCYTHAEMIA Search ESSENTIAL+THROMBOCYTHAEMIA
10 IDIOPATHIC MYELOFIBROSIS 148 76% 2% 103 Search IDIOPATHIC+MYELOFIBROSIS Search IDIOPATHIC+MYELOFIBROSIS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 POLYCYTHEMIA VERA 1596 62% 26% 1668
2 ESSENTIAL THROMBOCYTHEMIA 1199 66% 17% 1099
3 MYELOID METAPLASIA 798 74% 9% 586
4 TYROSINE KINASE JAK2 790 71% 10% 632
5 AGNOGENIC MYELOID METAPLASIA 594 84% 5% 323
6 CHRONIC MYELOPROLIFERATIVE DISORDERS 517 72% 6% 406
7 MYELOPROLIFERATIVE DISORDERS 497 45% 13% 829
8 MYELOFIBROSIS 441 55% 8% 551
9 IDIOPATHIC MYELOFIBROSIS 421 72% 5% 334
10 RISK ESSENTIAL THROMBOCYTHEMIA 272 98% 1% 65

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CURRENT HEMATOLOGIC MALIGNANCY REPORTS 3 10% 0% 24

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
CME Information: Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification, and management 2015 8 94 88%
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms 2008 437 72 67%
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms 2014 35 31 71%
Medical progress: Myelofibrosis with myeloid metaplasia. 2000 388 74 78%
Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies 2011 112 80 89%
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 2010 205 127 61%
New mutations and pathogenesis of myeloproliferative neoplasms 2011 135 167 56%
Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond 2011 100 137 69%
Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation 2004 158 83 86%
Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders 2007 222 90 61%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HEMATOL BLOOD COAGULAT 52 68% 0.7% 46
2 STUDY MYELOFIBROSIS 46 71% 0.6% 37
3 CONGIUNTO MMPC 17 100% 0.1% 8
4 THROMBOCYTHEMIA VERA STUDY GRP 14 100% 0.1% 7
5 MYELOPROLIFERAT DISORDERS CONSORTIUM 12 86% 0.1% 6
6 EUROPEAN WORKING GRP MYELOPROLIFERAT DISORDERS 11 100% 0.1% 6
7 GOODHEART 10 61% 0.2% 11
8 LEUKEMIA SERV 10 19% 0.7% 45
9 UNIT CLIN IMMUNOL IMMUNOHEMATOL TRANSFUS SERV 9 83% 0.1% 5
10 HEMATOL INTERNAL MED 9 13% 1.0% 64

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000013620 MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA
2 0.0000013336 STAT3//INTERLEUKIN 7//SOCS
3 0.0000011228 THROMBOPOIETIN//ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR
4 0.0000010080 CHOLESTEROL CRYSTAL EMBOLIZATION//CHOLESTEROL EMBOLI//CHOLESTEROL CRYSTAL EMBOLISM
5 0.0000009950 GRANULOCYTIC SARCOMA//CHLOROMA//TUMOR LYSIS SYNDROME
6 0.0000008332 RELAPSING POLYCHONDRITIS//EOSINOPHILIC ANGIOCENTRIC FIBROSIS//GRANULOMA FACIALE
7 0.0000007685 EOSINOPHILIC ESOPHAGITIS//HYPEREOSINOPHILIC SYNDROME//EOSINOPHILIC GASTROENTERITIS
8 0.0000006977 XIST//X CHROMOSOME INACTIVATION//TSIX
9 0.0000006181 NEUROSCI REGENERAT//ERYTHROMELALGIA//NAV17
10 0.0000005691 ERYTHROPOIETIN//DARBEPOETIN ALFA//ANEMIA